Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Assessing real-world outcomes of treatment with ipilimumab and nivolumab in patients with metastatic clear cell renal cell carcinoma (ESMO Asia 2026) - Oct 1, 2026 - Abstract #433P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available 
Clinical • Metastases • Real-world • Real-world evidence • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Oncology • Solid Tumor
https://cslide.ctimeetingtech.com/asia2026/attendee/confcal/print/presentation/2425
 
Faria Arefin; Sophie O'haire; Michelle Forgione; Anthony Joshua; Arun Azad; Jeremy Shapiro; Chun Loo Gan; Andrew J. Weickhardt; Ganesalingam Pranavan; Annabel Smith; Felicia Roncolato; Ben Tran; Christopher Hocking
 
Oct 1, 2026
 
Prev Next